Clinical Trial Update: Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating neratinib and paclitaxel with or without pertuzumab and trastuzumab before combination chemotherapy in metastatic or locally advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)
• neratinib (neratinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Inflammatory Carcinoma, Locally Advanced Breast Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-02-12